Evidence map›Paper›PMID 37522807›Full record

ArticleDialogues in clinical neuroscience2022

The World Federation of Societies of Biological Psychiatry guidelines on the assessment and pharmacological treatment of compulsive sexual behaviour disorder.

Daniel Turner, Peer Briken, Joshua Grubbs, Leo Malandain, Gemma Mestre-Bach, Marc N Potenza, Florence Thibaut

Open access · diamondAbstract read
In one paragraph

Article in Dialogues in clinical neuroscience, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 30 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
30citing papers in PubMed, 2 pooled it
10.9field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

30 citing papers in PubMed, 2 syntheses or guidelines pooled it, 69 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Trial
  4. Trial
  5. Article
  6. Article
  7. Article
  8. Review
  9. Review
  10. Article
  11. Article
  12. Article
  13. A Pragmatic Approach to Sexual Health in Movement Disorders.Movement disorders clinical practice · 2025
    Review
  14. Review
  15. Review
  16. Article
  17. Review
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 7 institutions in 4 countries.

Daniel TurnerDepartment of Psychiatry and Psychotherapy, University Medical Center Mainz, Mainz, Germany.ORCID 0000-0003-2021-8253
Peer BrikenInstitute for Sex Research, Sexual Medicine, and Forensic Psychiatry, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.ORCID 0000-0002-1360-014X
Joshua GrubbsDepartment of Psychology, Bowling Green State University, Bowling Green, OH, USA.ORCID 0000-0002-2642-1351
Leo MalandainDepartment of Psychiatry and Addictive Disorders, University Hospital Cochin (site Tarnier) AP-HP, Paris, France.ORCID 0000-0003-3888-7690
Gemma Mestre-BachFacultad de Ciencias de la Salud, Universidad Internacional de La Rioja, La Rioja, Spain.ORCID 0000-0001-5345-0484
Marc N PotenzaDepartments of Psychiatry and Neuroscience and Child Study Center, Yale School of Medicine, New Haven, CT, USA.ORCID 0000-0002-6323-1354
Florence ThibautDepartment of Psychiatry and Addictive Disorders, University Hospital Cochin (site Tarnier) AP-HP, Paris, France.ORCID 0000-0002-0204-5435
Bowling Green State University · USHôpital Cochin · FRInserm · FRJohannes Gutenberg University Mainz · DEUniversidad Internacional De La Rioja · ESUniversität Hamburg · DEYale University · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectivesThe current guidelines aim to evaluate the role of pharmacological agents in the treatment of patients with compulsive sexual behaviour disorder (CSBD). They are intended for use in clinical practice by clinicians who treat patients with CSBD.

methodsAn extensive literature search was conducted using the English-language-literature indexed on PubMed and Google Scholar without time limit, supplemented by other sources, including published reviews.

resultsEach treatment recommendation was evaluated with respect to the strength of evidence for its efficacy, safety, tolerability, and feasibility. Psychoeducation and psychotherapy are first-choice treatments and should always be conducted. The type of medication recommended depended mainly on the intensity of CSBD and comorbid sexual and psychiatric disorders. There are few randomised controlled trials. Although no medications carry formal indications for CSBD, selective-serotonin-reuptake-inhibitors and naltrexone currently constitute the most relevant pharmacological treatments for the treatment of CSBD. In cases of CSBD with comorbid paraphilic disorders, hormonal agents may be indicated, and one should refer to previously published guidelines on the treatment of adults with paraphilic disorders. Specific recommendations are also proposed in case of chemsex behaviour associated with CSBD.

conclusionsAn algorithm is proposed with different levels of treatment for different categories of patients with CSBD.

Indexed as

Biological PsychiatryParaphilic DisordersSexual Dysfunctions, PsychologicalAdultCompulsive BehaviorHumansSexual Behavioraddictive behaviourschemsexcompulsive behavioursCompulsive sexual behaviour disorderhypersexualityparaphiliassexual addiction

Identifiers

PMID37522807
PMCPMC10408697
OpenAlexW4309426955

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.